TREX1 and cancer: We tested the anti-cancer therapeutic potential of abolishing TREX1 exonuclease activity using the genetically precise TREX1D18N mice (D18N mice), that express the mouse TREX1 D18N allele from its endogenous promoter that controls the level of expression in the appropriate genomic context.